CTRI/2018/06/014387招募中4 期
PHASE IV CLINICAL TRIAL TO EVALUATE THE SAFETY & EFFICACY OF GASTICA DROPS
试验速览
- 阶段
- 4 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Infants from 0 to 2 years of age.
- •2.Paroxysmal attacks of irritability and/or restlessness.
- •3.Crying is observed for more than 3 hours a day, three days a week for one week.
- •4.Infant of relatively sound health
- •5.Breastfed, Formula fed and Dairy milk fed infant
- •6.Crying sound is more intense than normal, like a high pitched scream
- •7.Crying even after feeding or rocking
- •8.Fist clenching while crying
- •9.Bending of arms and legs towards belly
- •10.Tightening stomach muscles
- •11.Passing gas while crying
- •12.Bloated tummy
- •13.Face turning red or flushed while crying
排除标准
- •1.Illiterate mothers
- •2.Premature birth or low birth weight ( <2500 g)
- •3.Failure to thrive
- •4.Gastrointestinal disorders
- •5.Currently infectious, allergic or metabolic disease
- •6.Children receiving any type of treatment (drug, herbal products or chiropractic manipulations
研究者
相似试验
进行中（未招募）
4 期
A study to evaluate safety and effectiveness of Apremilast drug in patients suffering from a disease of stiff and swollen joints (arthritis) along with disease of skin (psoriasis)CTRI/2019/01/017122Glenmark Pharmaceuticals Ltd
进行中（未招募）
4 期
Eye drops in Indian Subjects to treat dry eyeCTRI/2022/03/041175Alcon Research Ltd177
进行中（未招募）
1 期
A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX™ in Subjects =60 Years of AgeMedDRA version: 9.1 Level: LLT Classification code 10019974 Term: Herpes zosterHerpes ZosterEUCTR2007-000343-10-GBMerck & Co. Inc.12,000
撤回
4 期
A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX in Subjects >=60 Years of Ageshingles10047438Herpes ZosterNL-OMON31293Merck750
进行中（未招募）
不适用
A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX™ in Subjects =60 Years of AgeHerpes ZosterEUCTR2007-000343-10-DEMerck & Co., Inc.12,000